45 reports

  • Respiratory Complications Therapeutics Market, Global, Pipeline by Stage of Development, Molecule Type and Program Type, 2017
  • However, given GSK's vast overall product portfolio, respiratory complications contributes only a small proportion of total company revenue.

The primary endpoint was to determine safety and serum anti-F IgG antibody concentrations following immunization.

  • Cough And Cold
  • Tuberculosis
  • Market Size
  • Actelion Ltd
  • Pfizer Inc.

Monoclonal Antibodies ##.

  • Pathology
  • Tuberculosis
  • World
  • Demand

& nbsp; Also, the report:& nbsp; & nbsp; & nbsp; & nbsp; -& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and oth

  • Tuberculosis
  • Europe
  • Japan
  • World
  • Demand

& nbsp; Also, the report:& nbsp; & nbsp; & nbsp; & nbsp; -& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and oth

  • Medical Biotechnology
  • Tuberculosis
  • Europe
  • World
  • Demand

THE BIOSCIENCES DIVISION OF THE COMPANY DEALS WITH FLUORESCENCEACTIVATED CELL SORTERS AND ANALYZERS, MONOCLONAL ANTIBODIES AND KITS FOR PERFORMING CELL ANALYSIS, AND MOLECULAR INDEXING FOR GENOMICS RESEARCH.

  • Tuberculosis
  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company, Ltd
  • bioMerieux S.A.
  • Cepheid

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Trade

In addition to market share and sales forecasts, the report:-& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and other emerging Technologies; -& nbsp; Reviews features and

  • Medical Biotechnology
  • Tuberculosis
  • United States
  • Demand
  • Forecast

& nbsp; & nbsp; & nbsp; & nbsp; In addition to market share and sales forecasts, the report:-& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and other emerging Technol

  • Medical Biotechnology
  • Tuberculosis
  • Japan
  • Demand
  • Forecast

In addition to market share and sales forecasts, the report:-& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and other emerging Technologies; -& nbsp; Reviews features and

  • Medical Biotechnology
  • Tuberculosis
  • United Kingdom
  • Demand
  • Forecast

& nbsp; & nbsp; & nbsp; & nbsp; In addition to market share and sales forecasts, the report:-& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and other emerging Techno

  • Medical Biotechnology
  • Tuberculosis
  • Italy
  • Demand
  • Forecast

& nbsp; In addition to market share and sales forecasts, the report:-& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and other emerging Technologies; -& nbsp; Reviews fea

  • Medical Biotechnology
  • Tuberculosis
  • Germany
  • Demand
  • Forecast

& nbsp; In addition to market share and sales forecasts, the report:-& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and other emerging Technologies; -& nbsp; Reviews feat

  • Medical Biotechnology
  • Tuberculosis
  • France
  • Demand
  • Forecast

& nbsp; & nbsp; & nbsp; & nbsp; In addition to market share and sales forecasts, the report:-& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and other emerging Techno

  • Medical Biotechnology
  • Tuberculosis
  • Spain
  • Demand
  • Forecast

& nbsp; Also, the report:& nbsp; & nbsp; & nbsp; & nbsp; -& nbsp; Examines market applications of Molecular Diagnostics, & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; & nbsp; Monoclonal Antibodies, Immunoassays, IT and oth

  • Infectious Disease
  • Respiratory Disease
  • Tuberculosis
  • United States
  • Demand

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • GlaxoSmithKline plc

Monoclonal Antibodies ##.

  • Pathology
  • Tuberculosis
  • Forecast

Monoclonal Antibodies ##.

  • Pathology
  • Tuberculosis
  • Demand

Monoclonal Antibodies ##.

  • Pathology
  • Tuberculosis
  • Forecast

Monoclonal Antibodies ##.

  • Pathology
  • Tuberculosis
  • Demand

More than a few of these companies are focused on newer aspects of monoclonal antibody assays, nucleic acid probes, and a variety of amplification technologies, but nosocomial infections are not necessarily the key focus of this technology development.

  • Tuberculosis
  • Cepheid
  • Getinge Group
  • Roche Group
  • STERIS Corporation

Monoclonal Antibodies ##.

  • Pathology
  • Tuberculosis
  • Demand

The company expanded its offerings for the diagnosis and management of HIV infection with the introduction of Alere Determine HIV-##/ ## Ag/ Ab Combo in 2013, the first FDA-approved rapid, point-of-care test that detects both HIV-##/ ## antibodies and free HIV-

  • Tuberculosis
  • World
  • Market Size
  • Alere Inc.
  • Roche Group

Pasteur Institute NA NA MONOCLONAL ANTIBODY TO ANTAGONIZE FCGRIIA FOR AUTOIMMUNE ARTHRITIS, PULMONARY INFLAMMATION, SYSTEMIC ANAPHYLAXIS AND THROMBOCYTOPENIA - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description

  • Cough And Cold
  • Therapy
  • United States
  • World
  • Product Initiative

The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious diseases.

  • Tuberculosis
  • United States
  • World
  • Product Initiative
  • AmpliPhi Biosciences Corporation

As a result of these developments, both the number and diversity of molecule types in developmental pipelines have increased substantially, and are expected to continue to grow in the years to come - in particular monoclonal antibodies (mAb), proteins, peptides and vaccines.

  • Anti-Infective
  • Infectious Disease
  • Therapy
  • Tuberculosis
  • Deals & Alliance

Most recently she served as the Worldwide Brand Director at Novartis Pharmaceuticals Corporation, where she was the global launch lead for Aimovig®, the first monoclonal antibody approved by the U. S.

  • Clinical Trial
  • Cough And Cold
  • HIV AIDS
  • United States
  • AcelRx Pharmaceuticals, Inc.

The drug candidate is a monoclonal antibody that inhibits binding of IL-## to the ST## receptor.

  • Cough And Cold
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Completed ##-Oct-2014 ##. ## Product Description Monoclonal antibody conjugate was under development for the treatment of cancer and hematological tumors.

  • Cancer
  • Therapy
  • Tuberculosis
  • United States
  • MetaStat, Inc.

It also develops a product candidate, an anti-CD## monoclonal antibody that inhibits the production of adenosine produced by the tumor cells.

  • Cough And Cold
  • Pharmaceutical
  • Therapy
  • United States
  • Vernalis plc

PRV-## is an oral Colony Stimulating Factor-## Receptor (CSF-##R) small molecule inhibito and PRV-## is an anti-Toll-Like Receptor ## (TLR##) monoclonal antibody.

  • Tuberculosis
  • Belgium
  • United States
  • Company
  • Janssen Biotech, Inc.